Home » Medtronic Completes Enrollment in Postmarket Study of Drug-Eluting Stent
Medtronic Completes Enrollment in Postmarket Study of Drug-Eluting Stent
May 14, 2009
Medtronic, Inc. announced completion of enrollment in RESOLUTE International, a post-market study of its Resolute Drug-Eluting Stent.
Euro Investor
Euro Investor
Upcoming Events
-
21Oct